Literature DB >> 32214300

Percutaneous Transforaminal Endoscopic Lumbar Interbody Fusion for Degenerative Lumbar Diseases: A Consecutive Case Series with Mean 2-Year Follow-Up.

Mengran Jin1, Jun Zhang2, Haiyu Shao1, Jianwen Liu1, Yazeng Huang1.   

Abstract

BACKGROUND: Conventional open surgical procedures may cause massive dissections of the spine, higher perioperative complications, prolonged hospitalization, protracted rehabilitation programs and recovery. Percutaneous endoscopic lumbar interbody fusion (PELIF) is an evolving treatment option.
OBJECTIVES: To present the detailed procedure and preliminary clinical and radiologic results of PELIF for degenerative lumbar diseases. STUDY
DESIGN: A retrospective cohort study.
SETTING: A university affiliated tertiary hospital.
METHODS: The medical records of patients with degenerative lumbar diseases who underwent PELIF between January 2016 and December 2017 were retrospectively reviewed. Surgical level, surgical time, blood loss, hospital length of stay, and perioperative complications were discussed. Patients were also evaluated for pain by the Visual Analog Scale (VAS), and functional assessment by the Oswestry Disability Index (ODI) and the 36-Item Short Form Health Survey (SF-36), including Physical Component Summary (PCS) and Mental Component Summary (MCS) preoperatively, postoperatively, and during the follow-up period.
RESULTS: Thirty-nine consecutive patients (25 men and 14 women) with a mean age of 59.0 years (range, 39-77 years) were enrolled. The average surgical time was 213.8 ± 31.7 minutes (range, 185-324 minutes). Mean estimated blood loss was 25.0 ± 12.6 mL (range, 15-50 mL). At the latest follow-up visit, the VAS scores for back pain, leg pain, ODI, and SF-36 (MCS/PCS) scores improved 89.5%, 95.0%, 71.2%, and 37.5%/58%, respectively. Reoperations were performed in one patient for residual disc mass and one for misplacement of pedicle screw. Fusion was achieved in all patients. LIMITATIONS: The presented results are preliminary and should be interpreted taking the limitations into account, including nonrandomized design, relatively small sample size, and less intensive follow-up period.
CONCLUSIONS: The presented PELIF technique seems to be a promising surgical alternative for the treatment of patients with specific degenerative lumbar diseases. Randomized studies with larger sample size and long-term follow-up duration are needed to validate the superiorities of this versatile surgery. KEY WORDS: Endoscopic, minimally invasive spine surgery, lumbar interbody fusion, disc herniation, spondylolisthesis.

Entities:  

Year:  2020        PMID: 32214300

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  14 in total

1.  [Comparative study on effectiveness of percutaneous endoscopic and Wiltse-approach transforaminal lumbar interbody fusion in the treatment of lumbar spondylolisthesis].

Authors:  Guangduo Zhu; Yingjie Hao; Lei Yu; Panke Zhang; Shuyan Cao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-01-15

2.  [Current status and progress of minimally invasive percutaneous endoscopic lumbar interbody fusion].

Authors:  Xian Chang; Changqing Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-06-15

Review 3.  [Analysis of technical advantages and disadvantages of percutaneous endoscopic lumbar interbody fusion and its trend prospect].

Authors:  Bin Zhang; Qingquan Kong; Limin Rong
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-06-15

4.  [Comparison of effectiveness between percutaneous coaxial large-channel endoscopic lumbar interbody fusion and minimal invasive transforaminal lumbar interbody fusion in treatment of degenerative lumbar spinal stenosis].

Authors:  Junlin Liu; Qingquan Kong; Pin Feng; Bin Zhang; Junsong Ma; Yuan Hu; Xi Wu; Xiang Shu; Congmin Pu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-06-15

5.  [Clinical study on real-time three-dimensional CT navigation-guided full-endoscopic lumbar interbody fusion].

Authors:  Yang Yang; Jianwen Dong; Zhongyu Liu; Ruiqiang Chen; Zihao Chen; Zhengjia Zhai; Jiakun Qi; Limin Rong
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-06-15

6.  Radiation Dose Reduction and Surgical Efficiency Improvement in Endoscopic Transforaminal Lumbar Interbody Fusion Assisted by Intraoperative O-arm Navigation: A Retrospective Observational Study.

Authors:  Junfeng Gong; Xinle Huang; Liwen Luo; Huan Liu; Hao Wu; Ying Tan; Changqing Li; Yu Tang; Yue Zhou
Journal:  Neurospine       Date:  2022-06-30

7.  Efficacy of Single-Position Oblique Lateral Interbody Fusion Combined With Percutaneous Pedicle Screw Fixation in Treating Degenerative Lumbar Spondylolisthesis: A Cohort Study.

Authors:  Peng Cheng; Xiao-Bo Zhang; Qi-Ming Zhao; Hai-Hong Zhang
Journal:  Front Neurol       Date:  2022-06-15       Impact factor: 4.086

8.  A Narrative Review of Uniportal Endoscopic Lumbar Interbody Fusion: Comparison of Uniportal Facet-Preserving Trans-Kambin Endoscopic Fusion and Uniportal Facet-Sacrificing Posterolateral Transforaminal Lumbar Interbody Fusion.

Authors:  Hyeun Sung Kim; Pang Hung Wu; Koichi Sairyo; Il-Tae Jang
Journal:  Int J Spine Surg       Date:  2021-12

9.  Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study.

Authors:  Peng Yin; Haifeng Gao; Lijin Zhou; Daming Pang; Yong Hai; Jincai Yang
Journal:  Pain Res Manag       Date:  2021-12-20       Impact factor: 3.037

10.  Full-Endoscopic Lumbar Interbody Fusion for Treating Lumbar Disc Degeneration Involving Disc Height Loss: Technical Report.

Authors:  Tsuyoshi Harakuni; Hiroki Iwai; Yasushi Oshima; Hirokazu Inoue; Tomoaki Kitagawa; Hirohiko Inanami; Hisashi Koga
Journal:  Medicina (Kaunas)       Date:  2020-09-17       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.